B · Normal
[Tongrentang: Zuogui Pills obtained Canadian product license] On November 16, Tongrentang (600085.SH) announced that the company's subsidiary Tongrentang Pharmaceutical Factory received the "Product License (Category III)" approved and issued by Health Canada, and the product Zuogui Pills obtained Canadian product registration. This product is used in traditional Chinese medicine for indications such as nourishing the kidneys and nourishing yin, with a total R&D investment of approximately 2 million yuan. The approval this time is a product marketing authorization, and subsequent approvals such as production site certification must be completed. It will not have a significant impact on recent performance.
A-share announcement express 🕐 2026-11-16 16:19

Related telegraphs

Comments

0/500
Captcha (click to refresh)
No comments yet